Professional Supply Bulk 98% Astragalus Membranaceus Extract CAS 84687-43-4 Astragalus Root Extract Astragaloside IV

• Certification: RoHS, ISO, FDA
• Assay Method: HPLC, UV
• Application Form: Tablet, Capsule
• Application: Health Care Products, Medicine
• State: Powder
• Extract Source: Cordate Houttuynia
• Model NO.: TY-02AL
• CAS No.: 84687-43-4
• Appearance: Brown Powder
• Einecs: 616-396-9
• Assay: 99%
• Shelf: 2 Years
• Transport Package: 25kg/Drum 1kg, 10kg, 100kg, 200kg
• Specification: 25kg/drum
• Trademark: tongyon
• Origin: China
• Production Capacity: 5000kg/Month

Product Description

 

Product name	Astragaloside IV
CAS	84687-43-4
Appearance	brown  powder
Assay	99%
Storage	Cool and Protect from light

Product Name:Astragaloside IV
CAS:84687-43-4
MF:C41H68O14
MW:784.97
EINECS:1532714-185-1
Mol File:84687-43-4.mol    
Melting point:295-296°C
Boiling point:895.7±65.0 °C(Predicted)
Density 1.39
form neat




(1) Brain protection: astragaloside IV has a protective effect on brain injury in mice that induced by instant focal ischemia, which is related to its antioxidant effects, and astragaloside IV is expected to become the clinical drug in treatment of stroke. Astragaloside IV has a protective effect on blood-brain barrier after cerebral ischemia and reperfusion in rats.(2) Kidney protection: astragaloside IV has a protective effect on renal injury that induced by ischemia and reperfusion, and it can protect the kidney effectively when doing a kidney transplant, thus improve the success rate of transplant. Besides, astragaloside IV can down-regulate the content of monocyte chemoattractant protein-1 (MCP-1) in kidney tissues and the overexpression of mRNA.(3) Lung protection: astragaloside IV has a protective effect on lung injury that induced by ischemia and reperfusion, and it can reduce pulmonary bleeding and focal pulmonary hemorrhage in rats. Astragaloside IV can effectively inhibit ovalbumin-induced chronic asthma.(4) Myocardial protection: astragaloside IV can significantly improve myocardial ischemia and cardiac function in rats with myocardial infarction, and this effect is positively correlated with the dose and time. After the intraperitoneal injection of sterile Coxsackie virus (CVB3) to Balb/C mice, causing the myocarditis mice model, the mice were gavaged with 9% astragaloside IV for 7 days, the survival rate of mice with myocarditis increased, and the collagen synthesis and myocardium cell apoptosis reduced.(5) Liver protection: Astragaloside IV inhibits the collagen synthesis and proliferation of hepatic stellate cells, and has significant inhibition in fibrosis of liver cells.


GuangZhou TongYi biochemistry technology Co., Ltd is a company specializing in active pharmaceutical ingredient
(API), biology, plant extracts, chemical raw materials, fine chemicals, pharmaceutical intermediates, cosmetics raw
material. Our company has always adhered to the company philosophy of integrity, professionalism, quality first, and
customer service. With the efforts of all the company's employees, it has established long-term
and stable cooperative relations with many domestic and foreign customers, and won the unanimous trust of domestic
and foreign customers. With good comments, our company have made great progress.

Our company takes pioneering and innovative, high-quality and efficient as the code of conduct, and strives to provide
customers with efficient services,
high-quality products, and reasonable prices. We have established a customer demand-oriented, flexible, diverse and customizable service according to the different needs of different customers. Mode, and ultimately achieve the goal of
win-win.

Our company focuses on the future and the world, and will continue to devote itself to technological progress and the
development of new products in the future, hoping to work hand in hand with new and old friends at home and abroad
to create a better future.